MEG3 and asthma: Supporting these direct evidences of human studies linking low MEG3 expression to asthma development, an early in vitro experiment tested the effects of cigarette smoke condensate (CSC) treatment on gene expression of human bronchial epithelial cells (HBEC) and found MEG3 was down-regulated in CSC-treated cells (Hu et al., 2009).